45 completed, 13 terminated, 4 unknown, 4 withdrawn. 51 Phase 2, 14 Phase 1, 8 Phase 3, 4 Not applicable, 2 Phase 4.
Follow Antithymocyte Globulin: new trials by email Literature Review of Antithymocyte Globulin trials Research Report on Antithymocyte Globulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia Anti-Thymocyte Globulin, Biospecimen Collection, Bone Marrow Aspirate - Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia | Phase 1 | Recruiting | City of Hope Medical Center | 6 | 2024-11-15 | 2026-01-05 |
| A Study of TCD601 in de Novo Renal Transplant Recipients TCD601, belatacept, ATG - Renal Transplantation | Phase 2 | Completed | ITB-Med LLC | 76 | 2023-12-28 | 2026-05-05 |
| STOP-T1D Low-Dose (ATG) Antithymocyte Globulin, Placebo (for ATG) - Diabetes Mellitus, Type 1 | Phase 2 | Terminated | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 | 2023-11-01 | 2026-05-07 |
| Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy Romiplostim, Antithymocyte Globulin, Cyclosporine A - Severe Aplastic Anemia (SAA) | Phase 2 | Withdrawn | Amgen | 2023-08-31 | 2023-09-29 | |
| Selective CD28 Blockade in Renal Transplant Recipients Lulizumab, Tacrolimus, Thymoglobulin® - Kidney Transplantation, Renal Transplant Recipients | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-01-10 | 2023-03-22 | |
| Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation Individual Antithymocyte globulin, Antithymocyte globulin - Haploidentical Hematopoietic Stem Cell Transplantation | Phase 3 | Completed | Chinese PLA General Hospital | 204 | 2022-01-01 | 2026-01-21 |
| Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation Anti-Thymocyte Globulin, Busulfan, Cyclophosphamide - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 2 | Withdrawn | Fred Hutchinson Cancer Center | 2021-06-01 | 2021-06-30 | |
| Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation Antithymocyte Globulin - Haploidentical Hematopoietic Stem Cell Transplantation | Phase 2 | Unknown | Chinese PLA General Hospital | 63 | 2020-12-01 | 2023-04-11 |
| Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant Anti-Thymocyte Globulin, Cyclophosphamide, Cytokine-treated Veto Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 16 | 2019-08-08 | 2026-06-11 |
| RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT Cytarabine - Acute Leukemia, Myelodysplastic Syndromes | Phase 2 | Unknown | Peking University People's Hospital | 50 | 2018-02-01 | 2024-03-26 |
| RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT Cytarabine - Myelodysplastic Syndromes | Phase 2 | Unknown | Peking University People's Hospital | 50 | 2018-02-01 | 2022-04-20 |
| Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma Anti-Thymocyte Globulin, Busulfan, Clofarabine - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia | Phase 2 | Completed | M.D. Anderson Cancer Center | 6 | 2017-10-13 | 2023-10-11 |
| Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin - Kidney Transplant, Type 1 Diabetes | Phase 2 | Completed | Massachusetts General Hospital | 2 | 2017-01-01 | 2023-12-22 |
| Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients Thymoglobulin, Bortezomib, Tacrolimus - Acute Leukemia, Chronic Lymphocytic Leukemia | Phase 2 | Terminated | Emory University | 5 | 2016-09-01 | 2018-04-30 |
| Personalized NK Cell Therapy in CBT Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 100 | 2016-05-19 | 2026-11-02 |
| Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) living related donor partial liver transplantation, Total body irradiation, Bone marrow transplant from same donor - Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant) | Phase 2 | Withdrawn | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-01 | 2018-06-15 | |
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy HSCT from MSD, HSCT from MUD, HSCT from HRD - Acute Leukemia, Chronic Myeloid Leukemia | Not applicable | Completed | Nanfang Hospital, Southern Medical University | 876 | 2015-06-01 | 2020-03-05 |
| CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma Anti-Thymocyte Globulin, Cyclosporine, Mycophenolate Mofetil - Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma | Phase 2 | Completed | Robert Lowsky | 18 | 2015-06-01 | 2021-06-24 |
| Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant Allogeneic Bone Marrow Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Anti-Thymocyte Globulin - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission | Phase 1 | Completed | M.D. Anderson Cancer Center | 70 | 2014-03-06 | 2022-01-06 |
| Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients sirolimus, tacrolimus, mycophenolate - Disorder Related to Renal Transplantation, Cytomegalovirus Infections | Phase 4 | Completed | Associação Médico Espírita de Botucatu | 48 | 2014-01-01 | 2016-02-17 |
Showing 20 of 71. Sign in to see all of them.
Myelodysplastic Syndromes (25) · Leukemia, Myeloid, Acute (16) · Hodgkin Disease (11) · Leukemia (11) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (11) · Leukemia, Lymphocytic, Chronic, B-Cell (10) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (10) · Lymphoma, Non-Hodgkin (9) · Anemia, Aplastic (8) · Diabetes Mellitus, Type 1 (8) · Graft vs Host Disease (7) · Hematologic Neoplasms (7) · Lymphoma (7) · Anemia, Refractory, with Excess of Blasts (4) · Hypoglycemia (4)
M.D. Anderson Cancer Center (28) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · Fred Hutchinson Cancer Center (4) · Masonic Cancer Center, University of Minnesota (4) · Chinese PLA General Hospital (2) · Massachusetts General Hospital (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Peking University People's Hospital (2) · Amgen (1) · Associação Médico Espírita de Botucatu (1) · Beth Israel Deaconess Medical Center (1) · Children's Oncology Group (1) · City of Hope Medical Center (1) · Emory University (1) · Fate Therapeutics (1)
United States (62) · China (5) · Canada (3) · Australia (1) · Spain (1) · United Kingdom (1)
Andrew Posselt, MD, PhD (2) · Bernhard Hering, MD (2) · Camillo Ricordi, MD (2) · Chitra M. Hosing, MD (2) · Elizabeth Shpall, MD (2) · Issa Khouri (2) · Leona Holmberg (2) · Paolo Anderlini, MD (2) · Richard E. Champlin, MD (2) · Xiao-Jun Huang (2) · Xunrong Luo, MD, PhD (2) · Ali Naji, MD, PhD (1) · Ali Naji, PhD (1) · Amanda Olson (1) · Amin Alousi, MD (1)
PMID 20107229, PMID 20383216, PMID 20946966, PMID 23234514, PMID 23438305, PMID 23630300, PMID 23901089, PMID 23996087, PMID 24622416, PMID 25145344, PMID 25629445, PMID 25778529, PMID 26416896, PMID 27053235, PMID 27208317, PMID 27208344, PMID 27465220, PMID 28198767, PMID 29563196, PMID 31212080, PMID 33718234, PMID 37335960, PMID 37706580, PMID 39348419, PMID 39624016, PMID 39949947, PMID 40443407, PMID 42508748
P30CA016672 (4), P01CA148600 (2), P30CA015704 (2), 2009 (1), P01CA049605 (1), P01CA100265 (1), P30CA033572 (1), R01CA061508 (1), R01CA211044 (1), U01AI138909 (1), U10CA031946 (1), U10CA180821 (1), UC4DK117009-01 (1)